Genitourinary Malignancies Guidelines

Genitourinary Malignancies Co-Chairs & Task Force Members

Cancer Immunotherapy Guidelines-GU Kidney Co-Chairs

Task Force

Bill Bro – Kidney Cancer Association
Ron Bukowski, MD – Cleveland Clinic Taussig Cancer Institute
Bernard Faba – Patient Perspectives
Jo Faba – Patient Advocate
Robert A. Figlin, MD, FACP – Cedars-Sinai Medical Center
Hans Hammers, MD, PhD – Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Thomas Hutson, DO, PharmD – Charles A. Sammons Cancer Center/Baylor Medical Center
Eric Jonasch, MD – University of Texas MD Anderson Cancer Center
Richard W. Joseph, MD – Mayo Clinic
Bradley C. Leibovich, MD, FACS – Mayo Clinic
David F. McDermott, MD – Beth Israel Deaconess Medical Center/Dana-Farber/Harvard Cancer Center
Tom Olencki, DO – The Ohio State University Medical Center
Allan J. Pantuck, MD – University of California, Los Angeles Institute of Urologic Oncology
David I. Quinn, MD, PhD, MBBS, FRACP – University of Southern California Norris Comprehensive Cancer Center
Virginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center/Dana-Farber/Harvard Cancer Center
Martin Voss, MD – Memorial Sloan-Kettering Cancer Center
Christopher G. Wood, MD – University of Texas MD Anderson Cancer Center
Laura S. Wood, RN, MSN, OCN^® – Cleveland Clinic Taussig Cancer Institute

Cancer Immunotherapy Guidelines-GU Prostate Co-Chairs

James L. Gulley, MD, PhD, FACP – National Cancer Institute, National Institutes of Health
Douglas G. McNeel, MD, PhD – University of Wisconsin Carbone Cancer Center

Task Force

Neil Bander, MD – Weill Cornell Medical College
Tomasz M. Beer MD, FACP – Oregon Health & Science University Knight Cancer Institute
Charles G. Drake, MD, PhD – Johns Hopkins University
Lawrence Fong, MD – University of California, San Francisco
Stacey Harrelson, RN – Atlantic Urology Clinics
Philip W. Kantoff, MD – Memorial Sloan-Kettering Cancer Center
Ravi A. Madan, MD – National Cancer Institute, National Institutes of Health
William K. Oh, MD – Mount Sinai School Of Medicine
David J. Peace, MD – University of Illinois
Dan Petrylak, MD – Yale Cancer Center
Hank Porterfield – Alliance For Prostate Cancer Prevention
Oliver Sartor, MD – Tulane University School Of Medicine
Neal Shore, MD, FACS – Carolina Urologic Research Center
Susan Slovin, MD, PhD – Memorial Sloan-Kettering Cancer Center
Mark Stein, MD, FACP – Rutgers Cancer Institute Of New Jersey
Johannes Vieweg, MD, FACS – Nova Southeastern University

Cancer Immunotherapy Guidelines-GU Bladder Co-Chairs

Task Force

Prasanth Abraham, RN – University of Texas MD Anderson Cancer Center
Joaquim Bellmunt, MD – Dana-Farber Cancer Institute
Matthew Galsky, MD – Tisch Cancer Institute At Mount Sinai Medical Center
Badri Konety, MD, MBA – University of Minnesota
Donald Lamm, MD, FACS – Bladder Cancer Genitourinary Oncology
David Langham – Bladder Cancer Advocacy Network North Carolina Triangle Chapter
Cheryl Lee, MD – University of Michigan
Matthew Milowsky, MD – University of North Carolina
Mike O’Donnell, MD – University of Iowa
Peter O’Donnell, MD – University of Chicago
Daniel Petrylak, MD – Yale Cancer Center
Padmanee Sharma, MD, PhD – University of Texas MD Anderson Cancer Center
Eila Skinner, MD – Stanford University
Guru Sonpavde, MD – University of Alabama
John Taylor III, MD – University of Connecticut